Associate Professor of Dermatology (with tenure), Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center

Dermatology

works in the field of Dermatology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He has 10 awards "Elected to membership in the American Society for Clinical Investigation (ASCI)", "Thomas L. Shields, M.D. Endowed Professorship in Dermatology", "CMS Meaningful Use Stage 1 Certification", "Victor Newcomer Award", "Outstanding Teaching Award from the Dermatology residents", "President's Research Council Distinguished Young Researcher Award", "Young Investigator Award", "Physician Scientist Career Development Award", "Career Awards for Medical Scientists" and "Investigator Initiated Neurofibromatosis Research Program Award". Lu Q. Le is a published physician as well. He has 20 publications published. The latest was: A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M.

Publications

---

• Cells of Origin in the Embryonic Nerve Roots for NF1-Associated Plexiform Neurofibroma.
• BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors through Bim Induction.
• CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
• Preclinical therapeutic efficacy of a novel pharmacological inducer of apoptosis in malignant peripheral nerve sheath tumors.
• An exophytic, bleeding nodule on the left malar region.
• Recurrent perianal red plaque with superficial erosions and pustular exudate in a 16-month-old boy.
• Skin-Derived Precursors as a Source of Progenitors for Cutaneous Nerve Regeneration.
• Susceptible stages in Schwann Cells for NF1-associated plexiform neurofibroma development.
• Treatment of indeterminate Cell histiocytosis with pravastatin.
• Cutaneous features predict paraspinal neurofibromas in neurofibromatosis type 1.
• Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.
• Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human Cells.
• A case of simultaneously occurring Lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis.
• Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene.
• A DNA damage and stress inducible G protein-coupled receptor blocks Cells in G2/M.
• Regional gene therapy with a BMP-2-producing murine stromal Cell line induces heterotopic and orthotopic bone formation in rodents.
• Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.
• Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement.
• Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune Syndrome.

Schools

---

• University of California At Los Angeles

• St Mary39s Mercy Hospital

• Ut Southwestern Med Center

Procedures Preformed

---

• Destruction of Benign Skin Lesion
• Destruction of Malignant Skin Lesion

Conditions Treated

---

• Actinic Keratosis
• Basal Cell Carcinoma
• Bedsores
• Benign Skin Lesion
• View All

Doctors Specialties

---

• Dermatology

Accepted Insurances

---

Awards

---

• Elected to membership in the American Society for Clinical Investigation (ASCI)
• Thomas L. Shields, M.D. Endowed Professorship in Dermatology
• CMS Meaningful Use Stage 1 Certification
• Victor Newcomer Award
• Outstanding Teaching Award from the Dermatology residents
• President's Research Council Distinguished Young Researcher Award
• Young Investigator Award
• Physician Scientist Career Development Award
• Career Awards for Medical Scientists
• Investigator Initiated Neurofibromatosis Research Program Award

Education

---

• University of Texas Southwestern Medical School
• David Geffen School of Medicine at UCLA
• UCLA

Hospital

---

• University of Texas Southwestern Medical Center
• Children's Health System of Texas
• Parkland Health & Hospital System

Drug Facts

---

NPI NUMBER		1790814945
NPPES Provider LastName		LE
NPPES Provider FirstName		LU
NPPES Provider ZIPCode		753909069
NPPES Provider State		TX
Specialty Description		Dermatology
Total Claim Count		284.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1790814945
Last Name Of The Provider	LE
First Name Of The Provider	LU
View All

Similar Doctors

---

	Dr. Katherine O. Ayoade, MD This Doctor is OpenDoctor Recommended.
	Dr. Travis W. VanDergriff, MD This Doctor is OpenDoctor Recommended.
	Dr. Ahmad Y. Jabbar, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeri B. Foshee, MD This Doctor is OpenDoctor Recommended.
	Dr. Rebecca L. Euwer, MD This Doctor is OpenDoctor Recommended.
	Dr. Phillip J. Eichhorn, MD This Doctor is OpenDoctor Recommended.
	Dr. Ponciano D. Cruz Jr., MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Maria J. Quintanilla-Dieck, MD
	Dr. Arturo R. Dominguez, MD This Doctor is OpenDoctor Recommended.
	Lauren M. Parma, PA
	Dr. Lynne J. Roberts, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog